Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Sell
42
OCS Quote, Financials, Valuation and Earnings
Last price:
$20.50
Seasonality move
:
2.04%
Day range:
$20.08 - $21.11
52-week range:
$14.00 - $23.08
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
7.22x
Volume:
59.1K
Avg. volume:
114.3K
1-year change:
20.09%
Market cap:
$1.2B
Revenue:
--
EPS (TTM):
-$2.52
Analysts' Opinion
-
Consensus RatingOculis Holding AG has received a consensus rating of Buy. The company's average rating is a Buy based on 7 Buy ratings, 0 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $44.72, Oculis Holding AG has an estimated upside of 118.17% from its current price of $20.50.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $29.07 representing 100% downside risk from its current price of $20.50.
Fair Value
-
According to the consensus of 7 analysts, Oculis Holding AG has 118.17% upside to fair value with a price target of $44.72 per share.
OCS vs. S&P 500
-
Over the past 5 trading days, Oculis Holding AG has overperformed the S&P 500 by 3.79% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
Oculis Holding AG does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Oculis Holding AG has grown year-over-year revenues for 0 quarters straight. In the most recent quarter Oculis Holding AG reported revenues of --.
Earnings Growth
-
Oculis Holding AG has grown year-over-year earnings for 1 quarter straight. In the most recent quarter Oculis Holding AG reported earnings per share of -$0.40.
Enterprise value:
1B
EV / Invested capital:
--
Price / LTM sales:
--
EV / EBIT:
--
EV / Revenue:
--
PEG ratio (5yr expected):
-0.32x
EV / Free cash flow:
-13.76x
Price / Operating cash flow:
--
Enterprise value / EBITDA:
--
Gross Profit (TTM):
-$601.4K
Return On Assets:
-63.78%
Net Income Margin (TTM):
--
Return On Equity:
-84.11%
Return On Invested Capital:
-83.14%
Operating Margin:
--
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Income Statement | ||||||
| Revenue | -- | -- | -- | -- | -- | |
| Gross Profit | -$168.3K | -$402.6K | -$601.4K | -$137.3K | -$188.7K | |
| Operating Income | -- | -$78M | -$93.3M | -$21.2M | -$25.7M | |
| EBITDA | -- | -$77.6M | -$92.7M | -$21M | -$25.5M | |
| Diluted EPS | -$0.97 | -$2.01 | -$2.52 | -$0.56 | -$0.40 | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $1.2M | -- | $126.3M | $132.2M | $189.7M | |
| Total Assets | $128.7M | -- | $140.9M | $148.9M | $210.9M | |
| Current Liabilities | $235K | -- | $24.2M | $32.9M | $42.4M | |
| Total Liabilities | $7.4M | -- | $25.5M | $36M | $46.8M | |
| Total Equity | $121.3M | -- | $115.4M | $112.9M | $164.1M | |
| Total Debt | -- | -- | $751K | $1.5M | $3.1M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | -- | -$56.8M | -$71.4M | -$12.7M | -$17.8M | |
| Cash From Investing | -- | $5.5M | -$37.1M | $4.2M | -$4.6M | |
| Cash From Financing | -- | $58.8M | $129.5M | $655.2K | $2M | |
| Free Cash Flow | -- | -$57M | -$73.1M | -$12.9M | -$18M | |
OCS
Sector
Market Cap
$1.2B
$28.2M
Price % of 52-Week High
88.82%
51.2%
Dividend Yield
0%
0%
Shareholder Yield
-14.15%
-1.54%
1-Year Price Total Return
20.09%
-18.1%
Beta (5-Year)
--
0.516
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Buy
Level
$20.25
200-day SMA
Buy
Level
$18.72
Bollinger Bands (100)
Buy
Level
17.47 - 20.57
Chaikin Money Flow
Sell
Level
-2.1M
20-day SMA
Buy
Level
$20.15
Relative Strength Index (RSI14)
Buy
Level
53.63
ADX Line
Buy
Level
25.27
Williams %R
Neutral
Level
-49.635
50-day SMA
Buy
Level
$20.09
MACD (12, 26)
Buy
Level
0.23
25-day Aroon Oscillator
Buy
Level
16
On Balance Volume
Neutral
Level
2.1M
Financial Scores
Buy
Altman Z-Score
(Annual)
Level (3.791)
Sell
CA Score
(Annual)
Level (-2.2903)
--
Beneish M-Score
(Annual)
Level (--)
Buy
Momentum Score
Level (8)
Sell
Ohlson Score
Level (5.2889)
--
Piotroski F Score
(Annual)
Level (--)
Sell
Quality Ratio Score
Level (1)
Buy
Fundamental Score
Level (3)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Oculis Holding AG is a global biopharmaceutical company, which engages in sight and improving eye care. The firm's pipeline includes multiple product candidates in development such as, OCS-01, a topical retinal candidate for diabetic macular edema, OCS-02, a topical biologic candidate for dry eye disease, and OCS-05, a disease modifying candidate for acute optic neuritis and other neuro-ophtha disorders such as glaucoma, diabetic retinopathy, geographic atrophy, and neurotrophic keratitis. The company was founded in 2016 and is headquartered in Zug, Switzerland.
Stock Forecast FAQ
In the current month, OCS has received 7 Buy ratings 0 Hold ratings, and 0 Sell ratings. The OCS average analyst price target in the past 3 months is $44.72.
-
Where Will Oculis Holding AG Stock Be In 1 Year?
According to analysts, the consensus estimate is that Oculis Holding AG share price will rise to $44.72 per share over the next 12 months.
-
What Do Analysts Say About Oculis Holding AG?
Analysts are divided on their view about Oculis Holding AG share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Oculis Holding AG is a Sell and believe this share price will drop from its current level to $29.07.
-
What Is Oculis Holding AG's Price Target?
The price target for Oculis Holding AG over the next 1-year time period is forecast to be $44.72 according to 7 Wall Street analysts, 7 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is OCS A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Oculis Holding AG is a Buy. 7 of 7 analysts rate the stock a Buy at this time.
-
How Can I Buy Shares Of OCS?
You can purchase shares of Oculis Holding AG via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Oculis Holding AG shares.
-
What Is The Oculis Holding AG Share Price Today?
Oculis Holding AG was last trading at $20.50 per share. This represents the most recent stock quote for Oculis Holding AG. Yesterday, Oculis Holding AG closed at $20.50 per share.
-
How To Buy Oculis Holding AG Stock Online?
In order to purchase Oculis Holding AG stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Related Companies
Get OCS Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
OCS
Sector
P/E ratio
--
23.92x
PEG ratio
-0.32x
-0.01x
P/B ratio
7.22x
1.83x
Price / LTM sales
--
1.61x
Growth Metrics
OCS
Sector
Revenue growth
--
4.6%
Earnings growth
27.84%
10.88%
Revenue (5-year growth)
--
6.46%
Earnings forecast
-$0.54
-$0.21
Profitability
OCS
Sector
Profitability FY 2024
-$461K
$3.5M
Return on invested capital
-83.14%
-31.84%
Return on assets
-63.78%
-27.96%
Return on equity
-84.11%
-37.63%
Earnings Date
Last Earnings Date
Nov
10
Next Earnings Date
Mar
3
Estimated Next Earnings Date
Feb
9
Balance Sheet
OCS
Sector
Total cash
$182.5M
$26.3M
Short term investments
$78.5M
$25.7M
Total assets
$132.8M
$76.9M
Long term debt
$3.1M
$3.3M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is SentinelOne Stock Undervalued?
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Is Broadcom Stock on Sale?
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Stock Ideas
Buy
59
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 65x
Buy
55
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 37x
Buy
61
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 39x
Alerts
Buy
72
GLTO alert for Dec 27
Galecto, Inc. [GLTO] is up 16.92% over the past day.
Sell
20
SMX alert for Dec 27
SMX (Security Matters) Plc [SMX] is down 15.76% over the past day.
Sell
11
CDNAF alert for Dec 27
Canadian Tire Corp. Ltd. [CDNAF] is down 10% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
